Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.
Based in Houston, CenterPoint Energy (CNP - Free Report) is in the Utilities sector, and so far this year, shares have seen a price change of 15.36%. Currently paying a dividend of $0.23 per share, the company has a dividend yield of 2.08%. In comparison, the Utility - Electric Power industry's yield is 3.1%, while the S&P 500's yield is 1.33%.
Looking at dividend growth, the company's current annualized dividend of $0.92 is up 4.5% from last year. Over the last 5 years, CenterPoint Energy has increased its dividend 5 times on a year-over-year basis for an average annual increase of 8.33%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. CenterPoint's current payout ratio is 51%, meaning it paid out 51% of its trailing 12-month EPS as dividend.
CNP is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $1.91 per share, which represents a year-over-year growth rate of 8.52%.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. But, not every company offers a quarterly payout.
Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, CNP presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #2 (Buy).
CenterPoint Energy (CNP - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for CenterPoint is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
For CenterPoint, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for CenterPointFor the fiscal year ending December 2026, this energy delivery company is expected to earn $1.91 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for CenterPoint. Over the past three months, the Zacks Consensus Estimate for the company has increased 0.1%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of CenterPoint to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Investors interested in Utilities stocks should always be looking to find the best-performing companies in the group. CenterPoint Energy (CNP - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Utilities sector should help us answer this question.
CenterPoint Energy is a member of the Utilities sector. This group includes 111 individual stocks and currently holds a Zacks Sector Rank of #16. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. CenterPoint Energy is currently sporting a Zacks Rank of #2 (Buy).
Over the past 90 days, the Zacks Consensus Estimate for CNP's full-year earnings has moved 0.1% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the most recent data, CNP has returned 15.4% so far this year. Meanwhile, stocks in the Utilities group have gained about 8.1% on average. As we can see, CenterPoint Energy is performing better than its sector in the calendar year.
Another stock in the Utilities sector, Evergy Inc (EVRG - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 19.5%.
For Evergy Inc, the consensus EPS estimate for the current year has increased 0% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Breaking things down more, CenterPoint Energy is a member of the Utility - Electric Power industry, which includes 63 individual companies and currently sits at #165 in the Zacks Industry Rank. This group has gained an average of 9.9% so far this year, so CNP is performing better in this area. Evergy Inc is also part of the same industry.
Investors interested in the Utilities sector may want to keep a close eye on CenterPoint Energy and Evergy Inc as they attempt to continue their solid performance.
Andra AP fonden purchased a new position in shares of CenterPoint Energy, Inc. (NYSE:CNP – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 103,900 shares of the utilities provider’s stock, valued at approximately $4,484,000.
Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. raised its position in CenterPoint Energy by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 82,381,128 shares of the utilities provider’s stock valued at $3,158,492,000 after acquiring an additional 719,803 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its position in CenterPoint Energy by 13.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 58,286,690 shares of the utilities provider’s stock worth $2,234,712,000 after purchasing an additional 6,794,535 shares in the last quarter. Capital Research Global Investors grew its stake in shares of CenterPoint Energy by 1.1% during the 4th quarter. Capital Research Global Investors now owns 20,941,909 shares of the utilities provider’s stock worth $802,916,000 after purchasing an additional 235,346 shares during the period. Geode Capital Management LLC grew its stake in shares of CenterPoint Energy by 1.0% during the 4th quarter. Geode Capital Management LLC now owns 17,023,720 shares of the utilities provider’s stock worth $650,189,000 after purchasing an additional 166,305 shares during the period. Finally, Norges Bank purchased a new position in shares of CenterPoint Energy during the 4th quarter valued at approximately $343,925,000. Hedge funds and other institutional investors own 91.77% of the company’s stock.
Analyst Ratings Changes CNP has been the subject of several analyst reports. Wall Street Zen cut shares of CenterPoint Energy from a “hold” rating to a “sell” rating in a research note on Saturday, April 25th. Barclays raised their price target on shares of CenterPoint Energy from $38.00 to $44.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 15th. Evercore set a $45.00 price objective on shares of CenterPoint Energy in a research report on Monday, May 4th. Bank of America lifted their price target on CenterPoint Energy from $42.00 to $44.00 and gave the company a “neutral” rating in a research note on Wednesday, April 15th. Finally, Truist Financial lowered their price target on CenterPoint Energy from $48.00 to $47.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $45.46.
Check Out Our Latest Stock Analysis on CNP
CenterPoint Energy Price Performance Shares of CenterPoint Energy stock opened at $43.71 on Thursday. The stock has a market capitalization of $28.60 billion, a P/E ratio of 26.82, a PEG ratio of 2.53 and a beta of 0.46. The business has a 50 day simple moving average of $43.06 and a two-hundred day simple moving average of $42.24. CenterPoint Energy, Inc. has a 12 month low of $36.59 and a 12 month high of $45.22. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.16 and a quick ratio of 1.04.
CenterPoint Energy (NYSE:CNP – Get Free Report) last issued its quarterly earnings results on Thursday, April 23rd. The utilities provider reported $0.56 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.02). CenterPoint Energy had a return on equity of 10.56% and a net margin of 11.38%.The firm had revenue of $2.98 billion for the quarter, compared to analysts’ expectations of $1.98 billion. During the same quarter in the previous year, the firm posted $0.53 earnings per share. As a group, analysts predict that CenterPoint Energy, Inc. will post 1.91 EPS for the current fiscal year.
CenterPoint Energy Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 10th. Stockholders of record on Thursday, August 20th will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, August 20th. This is a positive change from CenterPoint Energy’s previous quarterly dividend of $0.23. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.2%. CenterPoint Energy’s payout ratio is currently 56.44%.
CenterPoint Energy Company Profile (Free Report)
CenterPoint Energy, Inc (NYSE: CNP) is a Houston-based regulated utility company that provides electric and natural gas delivery services and related infrastructure operations. The company’s principal activities center on the transmission and distribution of electricity in the greater Houston metropolitan area and the distribution of natural gas to customers across several states in the Midwest and South. As a vertically integrated utility, CenterPoint focuses on the reliable delivery of energy through owned and operated networks of lines, pipelines and associated facilities.
CenterPoint’s core businesses include regulated electric transmission and distribution services, regulated natural gas distribution, and the operation and maintenance of energy infrastructure.
Further Reading Five stocks we like better than CenterPoint Energy Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for CenterPoint Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CenterPoint Energy and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAndra AP fonden Sells 77,228 Shares of Invitation Home $INVH
NEXT HEADLINE »ABN Amro Investment Solutions Sells 12,387 Shares of Air Products and Chemicals, Inc. $APD
Bessemer Group Inc. lifted its holdings in shares of CenterPoint Energy, Inc. (NYSE:CNP – Free Report) by 38.5% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 53,141 shares of the utilities provider’s stock after purchasing an additional 14,762 shares during the period. Bessemer Group Inc.’s holdings in CenterPoint Energy were worth $2,293,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. grew its holdings in CenterPoint Energy by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 82,381,128 shares of the utilities provider’s stock worth $3,158,492,000 after acquiring an additional 719,803 shares during the last quarter. T. Rowe Price Investment Management Inc. raised its stake in shares of CenterPoint Energy by 13.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 58,286,690 shares of the utilities provider’s stock worth $2,234,712,000 after acquiring an additional 6,794,535 shares during the last quarter. Capital Research Global Investors lifted its position in shares of CenterPoint Energy by 1.1% during the fourth quarter. Capital Research Global Investors now owns 20,941,909 shares of the utilities provider’s stock worth $802,916,000 after purchasing an additional 235,346 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of CenterPoint Energy by 1.0% during the fourth quarter. Geode Capital Management LLC now owns 17,023,720 shares of the utilities provider’s stock valued at $650,189,000 after purchasing an additional 166,305 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of CenterPoint Energy in the fourth quarter valued at approximately $343,925,000. 91.77% of the stock is owned by institutional investors.
CenterPoint Energy Stock Up 2.3% CNP stock opened at $43.71 on Thursday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.16 and a quick ratio of 1.04. The stock has a market capitalization of $28.60 billion, a P/E ratio of 26.82, a P/E/G ratio of 2.53 and a beta of 0.46. CenterPoint Energy, Inc. has a fifty-two week low of $36.59 and a fifty-two week high of $45.22. The business has a 50-day moving average of $43.06 and a 200-day moving average of $42.24.
CenterPoint Energy (NYSE:CNP – Get Free Report) last announced its earnings results on Thursday, April 23rd. The utilities provider reported $0.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.02). CenterPoint Energy had a net margin of 11.38% and a return on equity of 10.56%. The firm had revenue of $2.98 billion during the quarter, compared to analyst estimates of $1.98 billion. During the same period in the prior year, the business posted $0.53 EPS. On average, sell-side analysts anticipate that CenterPoint Energy, Inc. will post 1.91 earnings per share for the current fiscal year.
CenterPoint Energy Increases Dividend The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Thursday, August 20th will be issued a dividend of $0.24 per share. The ex-dividend date is Thursday, August 20th. This is a positive change from CenterPoint Energy’s previous quarterly dividend of $0.23. This represents a $0.96 annualized dividend and a yield of 2.2%. CenterPoint Energy’s dividend payout ratio is currently 56.44%.
Wall Street Analysts Forecast Growth CNP has been the topic of several research reports. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CenterPoint Energy in a report on Monday, June 15th. Wells Fargo & Company reissued an “overweight” rating and issued a $48.00 target price on shares of CenterPoint Energy in a research note on Tuesday, April 21st. Barclays boosted their target price on CenterPoint Energy from $38.00 to $44.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 15th. BMO Capital Markets cut their price target on CenterPoint Energy from $48.00 to $47.00 and set an “outperform” rating on the stock in a research note on Wednesday. Finally, Wall Street Zen cut CenterPoint Energy from a “hold” rating to a “sell” rating in a report on Saturday, April 25th. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $45.46.
Get Our Latest Report on CNP
CenterPoint Energy Company Profile (Free Report)
CenterPoint Energy, Inc (NYSE: CNP) is a Houston-based regulated utility company that provides electric and natural gas delivery services and related infrastructure operations. The company’s principal activities center on the transmission and distribution of electricity in the greater Houston metropolitan area and the distribution of natural gas to customers across several states in the Midwest and South. As a vertically integrated utility, CenterPoint focuses on the reliable delivery of energy through owned and operated networks of lines, pipelines and associated facilities.
CenterPoint’s core businesses include regulated electric transmission and distribution services, regulated natural gas distribution, and the operation and maintenance of energy infrastructure.
See Also Five stocks we like better than CenterPoint Energy Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for CenterPoint Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CenterPoint Energy and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEB&D White Capital Company LLC Boosts Stake in Invesco QQQ $QQQ
Wall Street expects a year-over-year increase in earnings on higher revenues when CenterPoint Energy (CNP - Free Report) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on July 28, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis energy delivery company is expected to post quarterly earnings of $0.36 per share in its upcoming report, which represents a year-over-year change of +24.1%.
Revenues are expected to be $2.11 billion, up 8.4% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.5% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for CenterPoint?For CenterPoint, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +2.07%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that CenterPoint will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that CenterPoint would post earnings of $0.58 per share when it actually produced earnings of $0.56, delivering a surprise of -3.45%.
Over the last four quarters, the company has beaten consensus EPS estimates just once.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
CenterPoint appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
California Public Employees Retirement System lowered its stake in shares of CenterPoint Energy, Inc. (NYSE:CNP – Free Report) by 27.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,194,133 shares of the utilities provider’s stock after selling 453,643 shares during the period. California Public Employees Retirement System owned approximately 0.18% of CenterPoint Energy worth $51,539,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Assetmark Inc. increased its position in CenterPoint Energy by 131.9% in the 1st quarter. Assetmark Inc. now owns 6,952 shares of the utilities provider’s stock valued at $300,000 after buying an additional 3,954 shares in the last quarter. Bessemer Group Inc. boosted its holdings in CenterPoint Energy by 38.5% in the first quarter. Bessemer Group Inc. now owns 53,141 shares of the utilities provider’s stock worth $2,293,000 after acquiring an additional 14,762 shares in the last quarter. Wealthfront Advisers LLC boosted its holdings in CenterPoint Energy by 27.6% in the first quarter. Wealthfront Advisers LLC now owns 193,710 shares of the utilities provider’s stock worth $8,361,000 after acquiring an additional 41,944 shares in the last quarter. D.A. Davidson & CO. acquired a new stake in CenterPoint Energy in the first quarter valued at approximately $202,000. Finally, Marks Group Wealth Management Inc grew its stake in CenterPoint Energy by 15.8% in the first quarter. Marks Group Wealth Management Inc now owns 59,527 shares of the utilities provider’s stock valued at $2,569,000 after acquiring an additional 8,131 shares during the period. Institutional investors own 91.77% of the company’s stock.
CenterPoint Energy Stock Performance Shares of CNP opened at $43.02 on Tuesday. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.04 and a current ratio of 1.16. The stock has a 50 day moving average price of $43.02 and a two-hundred day moving average price of $42.17. The firm has a market capitalization of $28.14 billion, a P/E ratio of 26.39, a P/E/G ratio of 2.56 and a beta of 0.46. CenterPoint Energy, Inc. has a 52 week low of $36.59 and a 52 week high of $45.22.
CenterPoint Energy (NYSE:CNP – Get Free Report) last issued its quarterly earnings data on Thursday, April 23rd. The utilities provider reported $0.56 EPS for the quarter, missing the consensus estimate of $0.58 by ($0.02). The company had revenue of $2.98 billion during the quarter, compared to analysts’ expectations of $1.98 billion. CenterPoint Energy had a return on equity of 10.56% and a net margin of 11.38%.During the same period last year, the company earned $0.53 earnings per share. CenterPoint Energy has set its FY 2026 guidance at 1.890-1.910 EPS. Equities analysts forecast that CenterPoint Energy, Inc. will post 1.91 earnings per share for the current fiscal year.
CenterPoint Energy Increases Dividend The business also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Thursday, August 20th will be given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, August 20th. This is an increase from CenterPoint Energy’s previous quarterly dividend of $0.23. CenterPoint Energy’s payout ratio is currently 56.44%.
Analysts Set New Price Targets A number of equities analysts have recently weighed in on CNP shares. BTIG Research started coverage on CenterPoint Energy in a research report on Tuesday, June 30th. They set a “neutral” rating on the stock. BMO Capital Markets lifted their price target on shares of CenterPoint Energy from $47.00 to $48.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th. Weiss Ratings restated a “buy (b)” rating on shares of CenterPoint Energy in a research note on Monday, June 15th. Bank of America boosted their price target on shares of CenterPoint Energy from $42.00 to $44.00 and gave the company a “neutral” rating in a research note on Wednesday, April 15th. Finally, Wells Fargo & Company restated an “overweight” rating and set a $48.00 price objective on shares of CenterPoint Energy in a report on Tuesday, April 21st. Eight investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $45.31.
Read Our Latest Research Report on CenterPoint Energy
CenterPoint Energy Profile (Free Report)
CenterPoint Energy, Inc (NYSE: CNP) is a Houston-based regulated utility company that provides electric and natural gas delivery services and related infrastructure operations. The company’s principal activities center on the transmission and distribution of electricity in the greater Houston metropolitan area and the distribution of natural gas to customers across several states in the Midwest and South. As a vertically integrated utility, CenterPoint focuses on the reliable delivery of energy through owned and operated networks of lines, pipelines and associated facilities.
CenterPoint’s core businesses include regulated electric transmission and distribution services, regulated natural gas distribution, and the operation and maintenance of energy infrastructure.
See Also Five stocks we like better than CenterPoint Energy The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for CenterPoint Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CenterPoint Energy and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBessemer Group Inc. Buys 35,173 Shares of Mohawk Industries, Inc. $MHK
NEXT HEADLINE »Future Fund LLC Makes New Investment in Broadcom Inc. $AVGO
, /PRNewswire/ -- CenterPoint Energy, Inc.'s (NYSE: CNP) Board of Directors yesterday declared a regular quarterly cash dividend of $0.2400 per share on the issued and outstanding shares of Common Stock payable on September 10, 2026, to shareholders of record at the close of business on August 20, 2026. This represents a $0.0100 increase over the April 2026 declared dividend per share and in line with CenterPoint's targeted annual dividend per share growth rate of 6%.
About CenterPoint Energy, Inc.
As the only investor owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Minnesota, Ohio and Texas. As of March 31, 2026, the company owned approximately $48 billion in assets. With approximately 8,800 employees, CenterPoint Energy and its predecessor companies have been in business for more than 150 years. For more information, visit CenterPointEnergy.com.
Forward-Looking Statement
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this news release, the words "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "objective," "plan," "potential," "predict," "projection," "should," "target," "will" or other similar words are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding our strategic, growth and capital plans, longer-term resiliency plans, and future performance and financial results, are based upon assumptions of management which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. Actual events and results may differ materially from those expressed or implied by these forward-looking statements. Any statements in this news release regarding future events that are not historical facts are forward-looking statements. Each forward-looking statement contained in this news release speaks only as of the date of this release or the date that such statement is made, as applicable. Important factors that could cause actual results to differ materially from those indicated by the provided forward-looking information include risks and uncertainties relating to: (1) business strategies and strategic initiatives; (2) CenterPoint Energy's ability to fund and invest planned capital, and the timely recovery of its investments; (3) financial market and general economic conditions; (4) the timing and impact of future regulatory, legislative and political actions or developments; and (5) other factors, risks and uncertainties discussed in CenterPoint Energy's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, Form 10-Q for the fiscal quarter ended March 31, 2026 and other reports CenterPoint Energy or its subsidiaries may file from time to time with the Securities and Exchange Commission.
Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued through Week 104Greater improvements observed in children with preexisting genu varum (leg bowing) COPENHAGEN, Denmark, June 30, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new radiographic data from Week 104 from the completed pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) in children with achondroplasia. In the trial, TransCon CNP-treated children demonstrated continued improvements in lower extremity alignment through up to two years of treatment, including improvements in tibial-femoral angle (TFA). As previously reported, improvements in annualized growth velocity were maintained and ACH-specific height Z-score increased with TransCon CNP treatment through Week 104. The data were presented by Leanne M. Ward, M.D., FRCPC, Professor of Pediatrics at the University of Ottawa and Children's Hospital of Eastern Ontario, during the 12th International Conference on Children's Bone Health (ICCBH 2026) held in Montreal, Canada.
“These results show that continuous exposure to active C-type natriuretic peptide (CNP) provided by once-weekly TransCon CNP positively affected skeletal growth and lower limb alignment in children with achondroplasia, with the potential to address serious complications of skeletal dysplasia that contribute to chronic pain, altered mobility, and need for surgical intervention,” said Dr. Ward. “These outcomes reinforce previously reported data showing TransCon CNP’s ability to support healthy and proportional growth, further highlighting its potential to advance pharmacological treatment for achondroplasia.”
ApproaCH Trial Design
ApproaCH was a randomized, double-blind, placebo-controlled pivotal trial in 84 children with achondroplasia aged 2–11 years, investigating TransCon CNP (100 µg/kg once-weekly) versus placebo for 52 weeks, followed by an open-label extension (OLE) in which all participants received TransCon CNP through Week 104. Radiographic assessments of lower extremity alignment were conducted at baseline, Week 52, and Week 104.
Highlights of Radiographic Assessments at Week 104 of the Pivotal ApproaCH Trial
Improvements in TFA and TFA Z-scores continued through Week 104 and were greater in children with baseline TFA ≥ 5°: The average TFA in all children treated with TransCon CNP during the double-blind period was 9.1° at baseline, decreasing to 7.7° at Week 52 and 6.9° at Week 104, reflecting a mean absolute change of -2.2 degrees over the two-year treatment period. In the subgroup of children with baseline TFA ≥ 5° (reflecting children with preexisting genu varum), the average TFA was 13.4° at baseline, decreasing to 11.3° at Week 52 and 9.6° at Week 104, reflecting a mean absolute change of -3.8 degrees over the two-year treatment period.The average TFA in children switching from placebo to TransCon CNP treatment at Week 52 was 11.5° at baseline, increasing to 11.8° at Week 52 and decreasing with TransCon CNP treatment to 10.1° at Week 104, reflecting a mean absolute change of -1.7 degrees during the OLE period. In the subgroup of children with baseline TFA ≥ 5°, the average TFA was 18.2° at baseline, increasing to 18.7° at Week 52 and decreasing with treatment to 14.9° at Week 104, reflecting a mean absolute change of -3.8 degrees during the OLE period.In children treated with TransCon CNP in the double-blind period, mean TFA Z-score was 3.62 at baseline and decreased to 3.15 at Week 52 and 2.96 at Week 104, reflecting a mean absolute change of -0.66 over the two-year treatment period. In the subgroup of children with baseline TFA ≥ 5°, mean TFA Z-score was 5.40 at baseline and decreased to 4.67 at Week 52 and 4.36 at Week 104, reflecting a mean absolute change of -1.04 over the two-year treatment period.In children switching from placebo to TransCon CNP at Week 52, mean TFA Z-score was 4.08 at baseline, increased to 4.76 at Week 52, and decreased to 4.28 at Week 104, reflecting a mean absolute change of -0.48 from Week 52 to Week 104. In the subgroup of children with baseline TFA ≥ 5°, mean TFA Z-score was 6.13 at baseline, increased to 7.56 at Week 52, and decreased to 6.35 at Week 104, reflecting a mean absolute change of -1.21 from Week 52 to Week 104. Results also showed that fibula-to-tibia length ratio remained stable in the overall clinical trial population during the open-label extension, reflecting proportional growth of the lower leg. Through up to two years of treatment, TransCon CNP was generally well tolerated, with a low rate of ISRs (all mild), no symptomatic hypotension, and no acceleration of bone age. Most adverse events in TransCon CNP-treated children were mild or moderate, with none leading to treatment discontinuation or withdrawal from the trial.
A slide presentation with these data will be made available on the Investors & News section of the Ascendis Pharma website: https://investors.ascendispharma.com.
About TransCon CNP
TransCon CNP is a prodrug of C-type natriuretic peptide (CNP) administered once weekly, designed to provide continuous exposure of active CNP to receptors on tissues throughout the body to counteract the overactive FGFR3 signaling in achondroplasia. In February 2026, TransCon CNP was approved by the U.S. Food & Drug Administration (FDA) under the trade name YUVIWEL® to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses. Ascendis Pharma’s Marketing Authorisation Application for YUVIWEL is under review by the European Medicines Agency, with a regulatory decision anticipated in the fourth quarter of 2026.
About Achondroplasia
Achondroplasia is a rare genetic condition arising from a systemic fibroblast growth factor receptor 3 (FGFR3) variant that leads to an imbalance in the effects of the FGFR3 and CNP signaling pathways, estimated to affect more than 250,000 people worldwide. While historically considered a bone growth disorder, the FGFR3 variant seen in achondroplasia is expressed in tissues throughout the body, and is associated with an increased risk of muscular, neurological, and cardiorespiratory complications in addition to skeletal dysplasia. Medical complications of achondroplasia can vary from individual to individual and across different stages of life. Throughout infancy and childhood, observed complications include spinal abnormalities, enlarged brain ventricles, impaired muscle strength and reduced stamina, hearing deficits and chronic ear infections, upper airway obstructions, sleep-disordered breathing, hip problems, leg bowing, and chronic pain; some of which persist or worsen in adulthood. These medical complications can affect physical well-being and quality of life, and may be impacted by a range of individual, clinical, and social factors. Some individuals with achondroplasia require multiple procedures and surgeries to address specific functional or anatomical concerns.
About Ascendis Pharma A/S
Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.
Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Ascendis’ future operations, plans and objectives of management are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of such statements include, but are not limited to, statements relating to (i) TransCon CNP’s ability to address serious complications of skeletal dysplasia, including those that contribute to chronic pain, altered mobility, and need for surgical intervention, (ii) TransCon CNP’s ability to deliver healthy and proportional growth and its potential to advance pharmacological treatment of achondroplasia, (iii) the anticipated timing of a regulatory decision by the European Medicines Agency regarding YUVIWEL, (iv) Ascendis’ ability to apply its TransCon technology platform to make a meaningful difference for patients and (v) Ascendis’ use of TransCon to create new and potentially best-in-class therapies. Ascendis may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Ascendis makes, including, without limitation: dependence on third‑party manufacturers, distributors, and service providers for Ascendis’ products and product candidates; risks related to regulatory review and approval, including the possibility of delays, requests for additional data or analyses, restrictions or limitations on use, approval with labeling that is more limited than expected, or failure to obtain approval in the United States, European Union, or other jurisdictions; clinical development risks, including that results from ongoing or future trials may not confirm earlier data; unforeseen safety or efficacy findings in development programs or on‑market products; manufacturing, supply chain, quality, or logistics issues that could delay development or commercialization; unforeseen expenses related to commercialization of any approved Ascendis products; unforeseen research and development or selling, general and administrative expenses and other costs impacting Ascendis’ business generally; market acceptance, pricing, and reimbursement challenges, including payer coverage decisions and health technology assessments; competitive developments, including new or improved therapies; intellectual property protection, freedom‑to‑operate, and litigation risks; Ascendis’ ability to obtain additional funding, if needed, to support its business activities; cybersecurity, data privacy, and information technology disruptions; and the impact of international economic, political, legal, compliance, public health, and business factors, including tariffs, trade policies, currency fluctuations, and geopolitical events. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ascendis’ business in general, see Ascendis’ Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (SEC) on February 11, 2026, and Ascendis’ other future reports filed with, or submitted to, the SEC. Forward-looking statements do not reflect the potential impact of any future licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments that Ascendis may enter into or make. Ascendis does not assume any obligation to update any forward-looking statements, except as required by law.
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.
CenterPoint Energy (CNP - Free Report) is headquartered in Houston, and is in the Utilities sector. The stock has seen a price change of 10.98% since the start of the year. The energy delivery company is paying out a dividend of $0.23 per share at the moment, with a dividend yield of 2.16% compared to the Utility - Electric Power industry's yield of 2.98% and the S&P 500's yield of 1.44%.
Looking at dividend growth, the company's current annualized dividend of $0.92 is up 4.5% from last year. Over the last 5 years, CenterPoint Energy has increased its dividend 5 times on a year-over-year basis for an average annual increase of 8.33%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. CenterPoint's current payout ratio is 51%, meaning it paid out 51% of its trailing 12-month EPS as dividend.
Looking at this fiscal year, CNP expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $1.91 per share, with earnings expected to increase 8.52% from the year ago period.
From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. It's important to keep in mind that not all companies provide a quarterly payout.
High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. During periods of rising interest rates, income investors must be mindful that high-yielding stocks tend to struggle. With that in mind, CNP is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).
, /PRNewswire/ -- CenterPoint Energy, Inc.'s (NYSE: CNP) Board of Directors today declared a regular quarterly cash dividend of $0.2300 per share on the issued and outstanding shares of Common Stock payable on June 11, 2026, to shareholders of record at the close of business on May 21, 2026.
About CenterPoint Energy, Inc.
CenterPoint Energy, Inc. (NYSE: CNP) is a multi-state electric and natural gas delivery company serving approximately 7 million metered customers across Indiana, Minnesota, Ohio, and Texas. The company is headquartered in Houston and is the only Texas-domiciled investor-owned utility. As of December 31, 2024, the company had approximately $44 billion in assets. With approximately 8,300 employees, CenterPoint Energy and its predecessor companies have been serving customers for more than 150 years. For more information, visit CenterPointEnergy.com.
Forward-Looking Statement
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this news release, the words "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "objective," "plan," "potential," "predict," "projection," "should," "target," "will" or other similar words are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding our strategic, growth and capital plans, longer-term resiliency plans, and future performance and financial results, are based upon assumptions of management which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. Actual events and results may differ materially from those expressed or implied by these forward-looking statements. Any statements in this news release regarding future events that are not historical facts are forward-looking statements. Each forward-looking statement contained in this news release speaks only as of the date of this release or the date that such statement is made, as applicable. Important factors that could cause actual results to differ materially from those indicated by the provided forward-looking information include risks and uncertainties relating to: (1) business strategies and strategic initiatives; (2) CenterPoint Energy's ability to fund and invest planned capital, and the timely recovery of its investments; (3) financial market and general economic conditions; (4) the timing and impact of future regulatory, legislative and political actions or developments; and (5) other factors, risks and uncertainties discussed in CenterPoint Energy's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and other reports CenterPoint Energy or its subsidiaries may file from time to time with the Securities and Exchange Commission.
For more information, contact
Communications
[email protected]
New Director brings deep expertise in audit, governance, strategic planning and long-term financing as well as decades of experience serving the utility industry to the Board
, /PRNewswire/ -- As part of the ongoing refreshment process of its Board of Directors, CenterPoint Energy (NYSE: CNP) today announced that its shareholders elected a new Director, Michael A. ("Casey") Herman to its Board, effective April 16, 2026. Herman brings decades of audit, governance, and finance strategy experience in the electric and gas utility industries to CenterPoint's Board.
Herman is a senior industry executive with deep experience leading complex audits and providing consulting services for companies across the utility sector, including his 10 years of leading the U.S. Utility & Power Sector and Sustainability practices at PricewaterhouseCoopers (PwC). He has also served as a C-suite advisor and member of several utility industry-related boards, including as Chair of the Electric Power Research Institute's (EPRI) Advisory Committee and a member of the Edison Electric Institute's (EEI) Wall Street Advisory Group. He is a licensed Certified Public Accountant in Illinois and Louisiana.
"Casey is a well-respected thought leader in our industry having served numerous companies in the investor-owned utility space and he has a wealth and variety of experience that will greatly benefit CenterPoint's Board," said Jason P. Wells, Chair of CenterPoint's Board of Directors. "He brings decades of governance, audit, strategic planning, and long-term financing strategy expertise, especially when it comes to driving long-term strategic plans for Fortune 500 companies. We could not be more pleased to have him join us at this time."
Consistent with its growth-focused strategy and 10-year, $65.5 billion capital investment plan, CenterPoint continues to deliver on its objective to invest in the resilience, reliability and safety of its system and to fuel the company's long-term growth potential, for the benefit of its customers and communities across the service areas it serves.
Regarding his appointment, Herman said, "I am honored to be joining CenterPoint's Board and bringing my perspective to the table. As we all work together to support the company's goals of building and operating the most resilient coastal grid in the in the nation and the safest gas system in the country, I look forward to leveraging my experience and providing insights to the Board to help advance the company's long-term strategy."
About Michael A. "Casey" Herman
A former senior partner at PricewaterhouseCoopers, Casey Herman brings nearly four decades of experience advising companies across the energy, utility, and power sectors. During his tenure at PwC, he served as U.S. Utility and Power Sector Leader, where he led complex audits and provided strategic advisory services to Fortune 500 utility and energy companies. A licensed certified public accountant, Casey served as lead engagement partner for numerous large external audits, providing deep expertise in financial reporting, regulatory compliance, and SEC filings.
Casey holds a Bachelor of Science in Management from the A.B. Freeman School of Business at Tulane University where he also sits on the board. He also serves on the board of Dragos, Inc., a provider of cybersecurity for operational technology in the energy and industrial sectors.
About CenterPoint Energy, Inc.
As the only investor owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Minnesota, Ohio and Texas. As of December 31, 2025, the company owned approximately $46.5 billion in assets. With approximately 8,800 employees, CenterPoint and its predecessor companies have been in business for more than 150 years.
Forward-Looking Statement
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this news release, the words "anticipate," "believe," "continue," "could," "estimate," "expect," "forecast," "goal," "intend," "may," "objective," "plan," "potential," "predict," "projection," "should," "target," "will" or other similar words are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding our strategic, growth and capital plans, longer-term resiliency plans, and future performance and financial results, are based upon assumptions of management which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. Actual events and results may differ materially from those expressed or implied by these forward-looking statements. Any statements in this news release regarding future events that are not historical facts are forward-looking statements. Each forward-looking statement contained in this news release speaks only as of the date of this release or the date that such statement is made, as applicable. Important factors that could cause actual results to differ materially from those indicated by the provided forward-looking information include risks and uncertainties relating to: (1) business strategies and strategic initiatives; (2) CenterPoint Energy's ability to fund and invest planned capital, and the timely recovery of its investments; (3) financial market and general economic conditions; (4) the timing and impact of future regulatory, legislative and political actions or developments; and (5) other factors, risks and uncertainties discussed in CenterPoint Energy's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and other reports CenterPoint Energy or its subsidiaries may file from time to time with the Securities and Exchange Commission.
For more information, contact:
Communications
[email protected]
KBC Group NV boosted its holdings in CenterPoint Energy, Inc. (NYSE:CNP – Free Report) by 40.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 83,207 shares of the utilities provider’s stock after purchasing an additional 23,980 shares during the period. KBC Group NV’s holdings in CenterPoint Energy were worth $3,190,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of CNP. LBP AM SA raised its stake in shares of CenterPoint Energy by 12.2% during the 4th quarter. LBP AM SA now owns 93,878 shares of the utilities provider’s stock worth $3,599,000 after purchasing an additional 10,197 shares during the period. Farther Finance Advisors LLC boosted its holdings in shares of CenterPoint Energy by 4.0% in the 4th quarter. Farther Finance Advisors LLC now owns 15,948 shares of the utilities provider’s stock worth $611,000 after buying an additional 617 shares during the last quarter. Sage Mountain Advisors LLC grew its position in CenterPoint Energy by 75.5% during the fourth quarter. Sage Mountain Advisors LLC now owns 9,463 shares of the utilities provider’s stock valued at $363,000 after buying an additional 4,072 shares during the period. Tectonic Advisors LLC grew its position in CenterPoint Energy by 5.4% during the fourth quarter. Tectonic Advisors LLC now owns 15,112 shares of the utilities provider’s stock valued at $579,000 after buying an additional 771 shares during the period. Finally, Baillie Gifford & Co. increased its holdings in CenterPoint Energy by 5.4% during the fourth quarter. Baillie Gifford & Co. now owns 400,829 shares of the utilities provider’s stock worth $15,368,000 after buying an additional 20,502 shares during the last quarter. Institutional investors own 91.77% of the company’s stock.
Analyst Ratings Changes Several analysts have commented on CNP shares. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of CenterPoint Energy in a research report on Monday, December 29th. Wells Fargo & Company increased their target price on shares of CenterPoint Energy from $44.00 to $47.00 and gave the company an “overweight” rating in a research report on Tuesday, January 20th. BMO Capital Markets upgraded shares of CenterPoint Energy from a “market perform” rating to an “outperform” rating and set a $42.00 price target for the company in a research note on Tuesday, January 13th. Barclays lifted their price target on shares of CenterPoint Energy from $38.00 to $44.00 and gave the stock an “equal weight” rating in a report on Wednesday. Finally, Jefferies Financial Group increased their price objective on CenterPoint Energy from $44.00 to $49.00 and gave the company a “buy” rating in a report on Thursday. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $43.75.
View Our Latest Stock Report on CenterPoint Energy
CenterPoint Energy Price Performance NYSE CNP opened at $43.03 on Monday. The company has a quick ratio of 0.79, a current ratio of 0.91 and a debt-to-equity ratio of 1.84. The company has a market cap of $28.15 billion, a PE ratio of 26.89, a price-to-earnings-growth ratio of 2.55 and a beta of 0.54. CenterPoint Energy, Inc. has a 52 week low of $35.46 and a 52 week high of $44.47. The firm’s 50-day simple moving average is $42.91 and its two-hundred day simple moving average is $40.40.
CenterPoint Energy (NYSE:CNP – Get Free Report) last posted its earnings results on Thursday, February 19th. The utilities provider reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.01). CenterPoint Energy had a return on equity of 10.46% and a net margin of 11.24%.The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.23 billion. During the same quarter in the previous year, the business earned $0.40 EPS. CenterPoint Energy has set its FY 2026 guidance at 1.900- EPS. Research analysts predict that CenterPoint Energy, Inc. will post 1.75 earnings per share for the current year.
CenterPoint Energy Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 11th. Investors of record on Thursday, May 21st will be paid a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Thursday, May 21st. CenterPoint Energy’s payout ratio is currently 57.50%.
CenterPoint Energy Company Profile (Free Report)
CenterPoint Energy, Inc (NYSE: CNP) is a Houston-based regulated utility company that provides electric and natural gas delivery services and related infrastructure operations. The company’s principal activities center on the transmission and distribution of electricity in the greater Houston metropolitan area and the distribution of natural gas to customers across several states in the Midwest and South. As a vertically integrated utility, CenterPoint focuses on the reliable delivery of energy through owned and operated networks of lines, pipelines and associated facilities.
CenterPoint’s core businesses include regulated electric transmission and distribution services, regulated natural gas distribution, and the operation and maintenance of energy infrastructure.
Featured Stories Five stocks we like better than CenterPoint Energy
Receive News & Ratings for CenterPoint Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CenterPoint Energy and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEEmissary Wealth LLC Acquires New Holdings in Oracle Corporation $ORCL
NEXT HEADLINE »KBC Group NV Trims Stake in Ralph Lauren Corporation $RL
Analysts on Wall Street project that CenterPoint Energy (CNP - Free Report) will announce quarterly earnings of $0.60 per share in its forthcoming report, representing an increase of 13.2% year over year. Revenues are projected to reach $3.04 billion, increasing 4.1% from the same quarter last year.
Over the last 30 days, there has been a downward revision of 0.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
With that in mind, let's delve into the average projections of some CenterPoint metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts expect 'Revenues- Natural Gas Distribution' to come in at $1.90 billion. The estimate indicates a year-over-year change of +2.3%.
Analysts' assessment points toward 'Revenues- Electric Transmission and Distribution' reaching $1.22 billion. The estimate indicates a year-over-year change of +14.5%.
The consensus among analysts is that 'Operating Income / (loss)- Natural Gas Distribution' will reach $473.24 million. Compared to the current estimate, the company reported $433.00 million in the same quarter of the previous year.
Analysts predict that the 'Operating Income / (loss)- Electric Transmission and Distribution' will reach $277.09 million. The estimate compares to the year-ago value of $220.00 million.
View all Key Company Metrics for CenterPoint here>>>
CenterPoint shares have witnessed a change of +2.3% in the past month, in contrast to the Zacks S&P 500 composite's +9.3% move. With a Zacks Rank #2 (Buy), CNP is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
HOUSTON--(BUSINESS WIRE)--CenterPoint Energy, Inc. (NYSE: CNP), or “CenterPoint,” today reported net income of $316 million, or $0.48 per diluted share, on a GAAP basis for the first quarter of 2026, compared to $0.45 per diluted share in the comparable period of 2025. Non-GAAP EPS for the first quarter of 2026 was $0.56, compared to $0.53 per diluted share in the comparable period of 2025. These strong first-quarter results were primarily driven by growth and regulatory recovery, which contrib.
CenterPoint Energy (CNP - Free Report) came out with quarterly earnings of $0.56 per share, missing the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.53 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -3.78%. A quarter ago, it was expected that this energy delivery company would post earnings of $0.46 per share when it actually produced earnings of $0.45, delivering a surprise of -2.17%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
CenterPoint, which belongs to the Zacks Utility - Electric Power industry, posted revenues of $2.98 billion for the quarter ended March 2026, missing the Zacks Consensus Estimate by 1.44%. This compares to year-ago revenues of $2.92 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
CenterPoint shares have added about 9.9% since the beginning of the year versus the S&P 500's gain of 4.3%.
What's Next for CenterPoint?While CenterPoint has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for CenterPoint was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.39 on $2.14 billion in revenues for the coming quarter and $1.91 on $9.89 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Utility - Electric Power is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Duke Energy (DUK - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 5.
This electric utility is expected to post quarterly earnings of $1.79 per share in its upcoming report, which represents a year-over-year change of +1.7%. The consensus EPS estimate for the quarter has been revised 2.6% higher over the last 30 days to the current level.
Duke Energy's revenues are expected to be $8.46 billion, up 2.6% from the year-ago quarter.
Key Takeaways CNP reported Q1 adjusted EPS of 56 cents, missing estimates, though up 5.7% year over year.CenterPoint Energy posted $2.98B revenues, missing estimates but rising 2% from last year.CNP raised its 10-year capital plan to $65.5B and expects major data center load growth by 2029. CenterPoint Energy, Inc. (CNP - Free Report) reported first-quarter 2026 adjusted earnings of 56 cents per share, which missed the Zacks Consensus Estimate of 58 cents by 3.8%. However, the bottom line increased 5.7% from 53 cents in the year-ago quarter.
The company recorded GAAP earnings of 48 cents per share compared with 45 cents in the first quarter of 2025.
CNP’s RevenuesCNP generated revenues of $2.98 billion, which missed the Zacks Consensus Estimate of $3.04 billion by 1.4%. However, the top line improved 2% from the year-ago reported figure of $2.92 billion.
Highlights of CNP’s Q1 ReleaseTotal expenses increased 2% year over year to $2.32 billion.
CNP reported an operating income of $658 million compared with $649 million in the previous year.
Interest expenses and other finance charges totaled $265 million, up 13.2% from $234 million last year.
The company announced 12.2 gigawatts (GW) of firmly committed industrial load at Houston Electric, expecting 8 GW of data center load to be energized by 2029.
CNP’s Financial ConditionAs of March 31, 2026, CenterPoint Energy had cash and cash equivalents of $639 million compared with $38 million as of Dec. 31, 2025.
As of the aforementioned date, total long-term debt was $22.5 billion compared with $20.6 billion as of Dec. 31, 2025.
Net cash flow from operating activities during the first three months of 2026 amounted to $282 million compared with $410 million in the year-ago period.
The total capital expenditure for the quarter was $1.2 billion compared with $1.04 billion a year ago.
CNP’s 2026 GuidanceCenterPoint Energy has reiterated its 2026 non-GAAP EPS guidance of $1.89-$1.91, the midpoint of which would represent 8% growth over 2025 delivered results. The Zacks Consensus Estimate for earnings is pegged at $1.91 per share, which is the top end of the company’s guided range.
The company announced a $500 million increase to its 10-year capital plan, bringing total capital expenditures to nearly $65.5 billion through 2035.
CNP’s Zacks RankThe company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Upcoming Utility ReleasesEdison International (EIX - Free Report) is scheduled to report first-quarter results on April 28, after market close. The Zacks Consensus Estimate for earnings is pegged at $1.71 per share, which suggests a year-over-year increase of 24.8%.
EIX’s long-term (three to five years) earnings growth rate is 9.43%. The Zacks Consensus Estimate for first-quarter sales is pinned at $3.85 billion, which implies a year-over-year improvement of 1.1%.
Alliant Energy (LNT - Free Report) is slated to report first-quarter results on April 30, after market close. The Zacks Consensus Estimate for earnings is pegged at 83 cents per share, flat year over year.
LNT’s long-term earnings growth rate is 7.15%. The Zacks Consensus Estimate for first-quarter sales is pinned at $1.17 billion, which implies year-over-year growth of 3.9%.
Public Service Enterprise Group (PEG - Free Report) is slated to report first-quarter results on May 5, before market open. The Zacks Consensus Estimate for earnings is pegged at $1.50 per share, which implies a year-over-year increase of 4.9%.
PEG’s long-term earnings growth rate is 7.05%. The Zacks Consensus Estimate for first-quarter sales is pinned at $3.28 billion, which implies a year-over-year rise of 1.9%.
CenterPoint Energy (CNP - Free Report) reported $2.98 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 1.9%. EPS of $0.56 for the same period compares to $0.53 a year ago.
The reported revenue represents a surprise of -1.44% over the Zacks Consensus Estimate of $3.02 billion. With the consensus EPS estimate being $0.58, the EPS surprise was -3.78%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how CenterPoint performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenues- Natural Gas Distribution: $1.76 billion versus $1.9 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4.8% change.Revenues- Electric Transmission and Distribution: $1.21 billion versus the two-analyst average estimate of $1.18 billion. The reported number represents a year-over-year change of +13.4%.Operating Income / (loss)- Natural Gas Distribution: $397 million compared to the $480.5 million average estimate based on two analysts.Operating Income / (loss)- Electric Transmission and Distribution: $261 million compared to the $232.8 million average estimate based on two analysts.View all Key Company Metrics for CenterPoint here>>>
Shares of CenterPoint have returned +0.1% over the past month versus the Zacks S&P 500 composite's +9.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
CenterPoint Energy (NYSE:CNP – Get Free Report) and Power Assets (OTCMKTS:HGKGY – Get Free Report) are both large-cap utilities companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.
Valuation and Earnings This table compares CenterPoint Energy and Power Assets”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CenterPoint Energy $9.36 billion 2.97 $1.05 billion $1.63 26.03 Power Assets $98.89 million 178.65 $800.08 million N/A N/A CenterPoint Energy has higher revenue and earnings than Power Assets.
Institutional & Insider Ownership 91.8% of CenterPoint Energy shares are owned by institutional investors. 0.2% of CenterPoint Energy shares are owned by company insiders. Comparatively, 1.0% of Power Assets shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations This is a breakdown of recent ratings for CenterPoint Energy and Power Assets, as reported by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CenterPoint Energy 1 6 7 1 2.53 Power Assets 0 0 0 0 0.00 CenterPoint Energy currently has a consensus price target of $44.15, suggesting a potential upside of 4.05%. Given CenterPoint Energy’s stronger consensus rating and higher probable upside, analysts clearly believe CenterPoint Energy is more favorable than Power Assets.
Risk & Volatility CenterPoint Energy has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, Power Assets has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500.
Dividends CenterPoint Energy pays an annual dividend of $0.92 per share and has a dividend yield of 2.2%. Power Assets pays an annual dividend of $0.16 per share and has a dividend yield of 1.9%. CenterPoint Energy pays out 56.4% of its earnings in the form of a dividend. CenterPoint Energy has raised its dividend for 5 consecutive years. CenterPoint Energy is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Profitability This table compares CenterPoint Energy and Power Assets’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets CenterPoint Energy 11.38% 10.56% 2.57% Power Assets N/A N/A N/A Summary CenterPoint Energy beats Power Assets on 13 of the 16 factors compared between the two stocks.
About CenterPoint Energy (Get Free Report)
CenterPoint Energy, Inc. operates as a public utility holding company in the United States. The company operates through two segments, Electric and Natural Gas. The Electric segment includes electric transmission and distribution services to electric customers and electric generation assets, as well as optimizes assets in the wholesale power market. The Natural Gas segment engages in the intrastate natural gas sales, and natural gas transportation and distribution for residential, commercial, industrial and institutional customers in Indiana, Louisiana, Minnesota, Mississippi, Ohio, and Texas; permanent pipeline connections through interconnects with various interstate and intrastate pipeline companies; and provides maintenance and repair services of home appliances to customers in Minnesota and home repair protection plans to natural gas customers in Indiana, Mississippi, Ohio, and Texas through a third party. It serves approximately 2,534,730 metered customers; owned 348 substations with transformer capacity of 79,719 megavolt amperes; and owned and operated 217 miles of intrastate pipeline in Louisiana and Texas. The company was founded in 1866 and is headquartered in Houston, Texas.
About Power Assets (Get Free Report)
Power Assets Holdings Limited, an investment holding company, engages in the generation, transmission, and distribution of electricity in Hong Kong, the United Kingdom, Australia, Mainland China, and internationally. It generates energy from thermal, renewable energy, and waste sources. The company also transmits and distributes oil and gas; and provides trust administration and management services. It has a generation capacity of 879 MW renewable energy/energy from waste, 5,262 MW gas fired, and 3,567 MW coal/oil fired; and operates 114,900 km of gas/oil pipeline, as well as 388,200 km of power network serving 19,790,000 customers. The company was formerly known as Hongkong Electric Holdings Limited and changed its name to Power Assets Holdings Limited in February 2011. Power Assets Holdings Limited was founded in 1889 and is based in Central, Hong Kong.
Receive News & Ratings for CenterPoint Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CenterPoint Energy and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEHead to Head Review: Huadi International Group (NASDAQ:HUDI) and Voestalpine (OTCMKTS:VLPNY)
NEXT HEADLINE »Jerash Holdings (US) (NASDAQ:JRSH) and Under Armour (NYSE:UA) Financial Contrast
COPENHAGEN, Denmark, May 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from a subgroup analysis showing that children with achondroplasia ≥5 years of age at enrollment treated with once-weekly TransCon CNP (navepegritide) in its pivotal ApproaCH Trial demonstrated significantly greater annualized growth velocity (AGV) compared to placebo at Week 52, and sustained these growth improvements through up to two years of treatment. The safety profile for this subgroup through up to two years of treatment was similar to the overall population, with a low rate of injection site reactions (ISRs, all mild), no symptomatic hypotension, and no acceleration of bone age. The data follow previously reported Week 104 results showing consistent improvements in growth and body proportionality in the overall population, and expand on data recently presented by M. Jennifer Abuzzahab, M.D. during PES 2026, the annual meeting of the Pediatric Endocrine Society.
“We are pleased to see confirmation of the expected sustained growth improvements in these children, with a consistent safety and tolerability profile,” said Aimee D. Shu, M.D., Executive Vice President of Endocrine & Rare Disease Medical Science and Chief Medical Officer at Ascendis Pharma. “These results, along with the improved skeletal alignment and body proportionality and positive changes in health-related quality of life previously reported for the overall populationi further highlight TransCon CNP’s ability to promote healthy, proportional growth in children with achondroplasia across age groups.”
ApproaCH Trial Design
ApproaCH was a randomized, double-blind, placebo-controlled pivotal trial in 84 children with achondroplasia aged 2–11 years, investigating TransCon CNP (100 µg/kg once-weekly) versus placebo for 52 weeks, followed by a 52-week open-label extension (OLE) period in which all participants received TransCon CNP through Week 104. Fifty-three of the 84 children were ≥5 years of age at the time of their enrollment in the trial.
Highlights of the ApproaCH Trial Data Through Week 104
Subgroup of children aged ≥5 years at enrollment
AGV (cm/year) LS MeanObserved Mean3 Week 52Week 52Week 104TransCon CNP(n=36)5.795.845.71Placebo/TransCon CNP1 (n=17)4.023.885.53TransCon CNP vs. Placebo, Treatment Difference
[95% CI]+1.78
[1.22, 2.33]
p<0.0001+1.972
[1.37, 2.56]
p<0.0001-
ACH-Specific Height Z-score,
Change from BaselineCDC-Based Height Z-score,
Change from BaselineLS MeanObserved Mean3LS MeanObserved Mean3Week 52Week 52Week 104Week 52Week 52Week 104TransCon CNP (n=36)+0.38+0.38+0.75+0.28+0.26+0.58Placebo/TransCon CNP1 (n=17)+0.07+0.07+0.46-0.05-0.02+0.36TransCon CNP vs. Placebo, Treatment Difference2
[95% CI]+0.31
[0.20, 0.42]
p<0.0001+0.30
[0.18, 0.42]
p<0.0001-
+0.32
[0.20, 0.44]
p<0.0001+0.29
[0.14, 0.44]
p=0.0004-
Note: The observed mean is a simple average of recorded measurements; the LS mean is a model-based estimated average that adjusts for selected variables, typically baseline patient characteristics, enabling a more balanced comparison across arms of a clinical trial.
1 Week 104 data reflects placebo patients that crossed over to TransCon CNP treatment at Week 52
2 Not presented at PES 2026; included for context
3 Treatment differences between TransCon CNP and placebo were estimated from a T-test
Through up to two years of treatment, the safety profile in children ≥5 years was similar to the overall population, with a low rate of ISRs (all mild), no symptomatic hypotension, and no acceleration of bone age. Most adverse events in TransCon CNP-treated children were mild or moderate, with none leading to treatment discontinuation or withdrawal from the trial.
A slide presentation with these data can be found on the Investor Relations & News section of the Ascendis Pharma website: https://investors.ascendispharma.com.
About TransCon CNP
TransCon CNP is a prodrug of C-type natriuretic peptide (CNP) administered once weekly, designed to provide continuous exposure of active CNP to receptors on tissues throughout the body to counteract the overactive FGFR3 signaling in achondroplasia. In February 2026, TransCon CNP was approved by the U.S. Food & Drug Administration (FDA) under the trade name YUVIWEL® to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses. Ascendis Pharma’s Marketing Authorisation Application for YUVIWEL is under review by the European Medicines Agency, with a regulatory decision anticipated in the fourth quarter of 2026.
About Achondroplasia
Achondroplasia is a rare genetic condition arising from a systemic fibroblast growth factor receptor 3 (FGFR3) variant that leads to an imbalance in the effects of the FGFR3 and CNP signaling pathways, estimated to affect more than 250,000 people worldwide. While historically considered a bone growth disorder, the FGFR3 variant seen in achondroplasia is expressed in tissues throughout the body, and is associated with an increased risk of muscular, neurological, and cardiorespiratory complications in addition to skeletal dysplasia. Medical complications of achondroplasia can vary from individual to individual and across different stages of life. Throughout infancy and childhood, observed complications include spinal abnormalities, enlarged brain ventricles, impaired muscle strength and reduced stamina, hearing deficits and chronic ear infections, upper airway obstructions, sleep-disordered breathing, hip problems, leg bowing, and chronic pain; some of which persist or worsen in adulthood. These medical complications can affect physical well-being and quality of life, and may be impacted by a range of individual, clinical, and social factors. Some individuals with achondroplasia require multiple procedures and surgeries to address specific functional or anatomical concerns.
About Ascendis Pharma A/S
Ascendis Pharma is a global biopharmaceutical company focused on applying our innovative TransCon technology platform to make a meaningful difference for patients. Guided by our core values of Patients, Science, and Passion, and following our algorithm for product innovation, we apply TransCon to develop new therapies that demonstrate best-in-class potential to address unmet medical needs. Ascendis is headquartered in Copenhagen, Denmark, and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more.
Forward-Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Ascendis’ future operations, plans and objectives of management are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of such statements include, but are not limited to, statements relating to (i) TransCon CNP’s ability to promote healthy, proportional growth in children with achondroplasia across age groups, (ii) Ascendis’ ability to apply its TransCon technology platform to make a meaningful difference for patients and (iii) Ascendis’ use of TransCon to create new and potentially best-in-class therapies. Ascendis may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Ascendis makes, including, without limitation: dependence on third‑party manufacturers, distributors, and service providers for Ascendis’ products and product candidates; risks related to regulatory review and approval, including the possibility of delays, requests for additional data or analyses, restrictions or limitations on use, approval with labeling that is more limited than expected, or failure to obtain approval in the United States, European Union, or other jurisdictions; clinical development risks, including that results from ongoing or future trials may not confirm earlier data; unforeseen safety or efficacy findings in development programs or on‑market products; manufacturing, supply chain, quality, or logistics issues that could delay development or commercialization; unforeseen expenses related to commercialization of any approved Ascendis products; unforeseen research and development or selling, general and administrative expenses and other costs impacting Ascendis’ business generally; market acceptance, pricing, and reimbursement challenges, including payer coverage decisions and health technology assessments; competitive developments, including new or improved therapies; intellectual property protection, freedom‑to‑operate, and litigation risks; Ascendis’ ability to obtain additional funding, if needed, to support its business activities; cybersecurity, data privacy, and information technology disruptions; and the impact of international economic, political, legal, compliance, public health, and business factors, including tariffs, trade policies, currency fluctuations, and geopolitical events. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ascendis’ business in general, see Ascendis’ Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (SEC) on February 11, 2026, and Ascendis’ other future reports filed with, or submitted to, the SEC. Forward-looking statements do not reflect the potential impact of any future licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments that Ascendis may enter into or make. Ascendis does not assume any obligation to update any forward-looking statements, except as required by law.
Emergency exercise, building on CenterPoint's year-round emergency preparedness activities and drills, simulated a response to a major hurricane to strengthen future preparedness, coordination with local emergency agencies and first responders, as well as public and customer communications
, /PRNewswire/ -- Today, as part of an ongoing effort to strengthen its overall emergency preparedness and response efforts, CenterPoint Energy conducted its annual full-scale emergency response exercise in preparation for the upcoming hurricane season. The emergency exercise, held at CenterPoint's Emergency Operations Center, simulated a Category 3 hurricane impacting the Greater Houston area and included more than 400 members of CenterPoint teams – from Electric and Gas Operations, Emergency Planning & Response, Customer, Communications and others – executing the company's emergency response plan. About 100 state and local officials, emergency management officials, first responder partners and emergency experts observed the drill.
"For CenterPoint, preparing for natural disasters before they happen and simulating the effectiveness of our response and plans is vital to continuously improving and strengthening our response when future storms and hurricanes strike. Today's emergency exercise builds on the series of preparedness actions we've already taken throughout the year, as well as the continued infrastructure investments made as part of our Greater Houston Resiliency Initiative to strengthen the electric grid. The combination of actions we've taken are to help us better achieve the high level of performance expected of us, so we can restore power safely and more quickly for the millions of customers and families who depend on us," said Jesus Soto Jr., Executive Vice President and Chief Operating Officer, CenterPoint Energy.
2026 Preparedness: Focus of annual full-scale exercise
The 2026 emergency exercise focused on executing a series of critical emergency response activities, including reviewing weather forecasts and impacts, analyzing damage prediction models to deploy resources, coordinating with emergency responders to support unified response operations, and communicating accurate and timely information to customers, as well as local and state leaders, on the scale of restoration efforts and progress.
The exercise simulated a Category 3 hurricane and included third-party expert evaluators that observed and provided feedback. CenterPoint will use the feedback to further improve, enhance and strengthen CenterPoint's emergency response preparedness, reflecting its year-round commitment to implementing the latest best practices and lessons learned following all emergency events, including hurricanes and other extreme storms.
More than 100 officials observed the exercise, including elected leaders, representatives from regional emergency management offices, Houston-area utilities, as well as key stakeholders from local education, healthcare and business communities.
2026 Preparedness: Scope of emergency actions to date
CenterPoint has taken a series of actions throughout 2026 to prepare for the upcoming hurricane season. Actions include:
Opened a new Emergency Operations Center to support CenterPoint's year-round situational awareness and emergency response readiness and closely coordinate with emergency response partners, local and state officials, media and other key stakeholders. Completed more than 25,000 hours of FEMA trainings across more than 800 employees. Increased the number of frontline workers CenterPoint can call upon to support emergency responses by up to 20 times its normal workforce. Improved the damage assessment process with faster damage identification and power restoration. Enhanced real-time weather monitoring with 150 new advanced weather stations. Greater Houston Resiliency Initiative (GHRI): Strengthening the grid
Since launching GHRI in 2024, CenterPoint has made a series of critical infrastructure investments to strengthen the grid to better withstand more extreme weather and improve day-to-day reliability for its customers. These ongoing actions, as part of GHRI, have included:
Installing 65,000+ stronger, more storm-resilient poles; Clearing 10,000+ miles of higher-risk vegetation near power lines; Undergrounding 500+ miles of power lines; and Installing 600+ automation devices capable of self-healing. Throughout 2026, CenterPoint will continue to make additional investments to further strengthen system resiliency and emergency preparedness. These combined resiliency actions will prevent CenterPoint customers from experiencing 150 million fewer outage minutes by the end of 2026.
To learn more about CenterPoint's preparedness actions and critical resiliency improvements across Greater Houston, visit: www.CenterPointEnergy.com/TakingAction.
About CenterPoint Energy, Inc.
As the only investor owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Minnesota, Ohio and Texas. As of March 31, 2026, the company owned approximately $47.8 billion in assets. With approximately 8,800 employees, CenterPoint Energy and its predecessor companies have been in business for more than 150 years. For more information, visit CenterPointEnergy.com.
For more information, contact:
Communications
[email protected]
CenterPoint Energy is rated a "Buy," driven by its robust Texas-focused growth pipeline and strong earnings outlook. CNP targets 7%-9% annual EPS growth through 2035, supported by rapid population gains, industrial demand, and a favorable regulatory environment. Despite ongoing equity issuance to fund a $65.5 billion cap-ex plan, CNP expects to deliver 8%-9% EPS growth and a 2.2% dividend yield.
Multi‑hazard intelligence strengthens storm readiness and restoration planning across CenterPoint's service territories
, /PRNewswire/ -- As extreme weather events grow more frequent and complex, CenterPoint Energy is continuing to strengthen how it plans, prepares for and responds to severe weather across its electric and gas service territory in Texas, Indiana, Ohio, and Minnesota, where the company serves approximately 7 million metered customers.
To support faster service restoration for customers following storms, CenterPoint is leveraging a new, first-of-its-kind integrated planning and operations platform developed in collaboration with Technosylva to deliver better outcomes for its customers and communities.Technosylva is a leading provider of wildfire, flooding, and extreme weather modeling and decision‑support software used by utilities, insurers, and public agencies to better anticipate risk and support operational response.
The platform brings together outage forecasting, high‑wind and winter storm modeling, flood risk insights, and wildfire intelligence into a single, system‑wide view. This integrated approach allows CenterPoint teams to monitor evolving conditions days in advance, align the right crews and resources ahead of impact, and improve restoration planning and response - while keeping customer safety at the forefront and helping reduce outage duration and restoration costs.
"Preparing for extreme weather today requires earlier insight and better coordination than ever before," said Jason Wells, Chair, President and Chief Executive Officer of CenterPoint Energy. "Our goal is to build the most resilient coastal grid in the nation to benefit our customers and communities. Technosylva's product gives us much clearer visibility into where impacts are most likely and allows us to mobilize crews more efficiently, support neighboring utilities when possible, and restore service faster for our customers."
CenterPoint's electric and natural gas systems are exposed to a wide range of weather‑related threats, including hurricanes, flooding, high winds, extreme heat and cold, and winter storms. The platform supports the company's long‑term strategy to strengthen grid resilience, improve operational readiness, and better prepare for increasingly complex weather events, all while reinforcing CenterPoint's continued commitment to its customers who depend on safe, reliable electric and natural gas service.
During recent weather events, CenterPoint teams used the platform's multi‑day outage forecasts and storm impact modeling to assess potential system impacts ahead of time, set appropriate emergency response levels, and pre‑position crews. In recent high‑wind events, outage forecasts closely aligned with actual system impacts, helping teams translate weather data into actionable response plans with greater confidence.
"CenterPoint Energy's leadership is visionary, investing to get ahead of extreme weather risk, not just to respond to it," said Bryan Spear, CEO of Technosylva. "Serving customers and communities who face the full spectrum of extreme weather, this enhanced risk intelligence platform helps CenterPoint to anticipate and prepare for events, including hurricanes, flooding, severe winds, and wildfire. We are grateful to them for their collaboration in developing our AI-powered platform, which delivers outage forecasting, restoration planning, flood insights, and wildfire intelligence, to help keep the lights on and restore power faster when it matters most."
Beyond immediate storm response, the platform also supports longer‑term planning by improving how flood and extreme weather risk are incorporated into infrastructure and capital investment decisions. As weather patterns evolve and infrastructure ages, asset‑level risk visibility is increasingly important for investments to deliver resilience benefits for customers over time.
About CenterPoint Energy, Inc.
As the only investor owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Minnesota, Ohio and Texas. As of March 31, 2026, the company owned approximately $47.8 billion in assets. With approximately 8,800 employees, CenterPoint Energy and its predecessor companies have been in business for more than 150 years. For more information, visit CenterPointEnergy.com.
About Technosylva
Technosylva is the leading provider of wildfire and extreme weather modeling, risk mitigation, and operational response software. Technosylva's market-leading solutions, enhanced by AI and machine learning capabilities, provide real-time and predictive insights into developing wildfire and extreme weather risks to support electric utility, insurance, and government agency customers. Founded in 1997, Technosylva has offices in La Jolla, CA, León, Spain, and Calgary, Canada. Learn more at www.Technosylva.com.
Media Contacts
CenterPoint Energy
[email protected]
Technosylva
Mahoney Communications Group
Emily Torrans
[email protected]
Ph. 212.220.6045
Choosing between Algonquin Power & Utilities (AQN +0.42%) and CenterPoint Energy (CNP +0.95%) requires balancing income potential against geographical reach. Both companies provide essential services, making them popular choices for everyday investors.
Algonquin operates a mix of regulated water, gas, and electric services across 13 states and multiple countries. CenterPoint focuses on massive delivery networks in major hubs like Houston, Minnesota, and Indiana. This comparison explores their financial health and valuations to help you decide which stock fits your strategy.
Algonquin manages a diverse portfolio through its Liberty brand, serving approximately 1.3 million customer connections. It provides electricity, natural gas, water, and wastewater services across North America, Chile, and Bermuda. Its operations span 13 U.S. states and one Canadian province, allowing the utility to benefit from diverse revenue streams and varied regulatory environments.
In FY 2025, revenue reached nearly $2.4 billion, representing a growth rate of close to 4.9% compared to the previous year. The company reported net income of approximately $208 million, which corresponds to a net margin of roughly 8.5%. This net margin reflects the percentage of total revenue remaining as profit after all expenses and taxes are paid, providing a look at the bottom-line efficiency.
As of its December 2025 balance sheet, the debt-to-equity ratio is nearly 1.4x. This ratio measures total debt against shareholder equity, where a higher number indicates more reliance on borrowed funds for expansion. The company reported a current ratio of roughly 1.0x, which shows its ability to cover short-term liabilities with current assets. Free cash flow was negative $249 million, which is calculated as operating cash minus capital spending. This metric is a key focus for those investing in utility stocks because it indicates the cash available for dividends or debt repayment.
The case for CenterPoint EnergyCenterPoint serves approximately 7 million metered customers through its electric and natural gas delivery networks in major regions. Its primary markets include Greater Houston and several Midwestern states like Minnesota and Indiana. Two major customers, NRG Energy and Vistra, account for nearly 60% of billed receivables in its Houston electric segment. Customer concentration like this adds a layer of risk to the business, as the company depends on these entities to remit payments on a timely basis.
For FY 2025, revenue reached nearly $9.4 billion, showing a year-over-year increase of approximately 8.3%. Net income for the period was roughly $1.1 billion, resulting in a net margin of close to 11.2%. This net margin signifies how much of every dollar in sales the utility kept as profit, and it remained relatively consistent compared to the previous year. These results highlight the scale of the company's delivery network in high-demand urban centers.
According to its December 2025 balance sheet, the company carries a debt-to-equity ratio of 2.1x. This indicates that its total liabilities are more than double its shareholder equity, a common trait for utilities with large infrastructure projects. The current ratio is approximately 0.9x, showing its liquidity position relative to short-term obligations.
Risk profile comparisonAlgonquin faces significant regulatory and operational risks as it manages water and electric services across diverse regions. Frequent rate case filings are necessary to recover the heavy costs of infrastructure maintenance and environmental compliance. Any failure to secure favorable terms from regulators can lead to lower net margins and reduced cash flow.
CenterPoint deals with regulatory lag and the risk that regulators may deny full cost recovery for its infrastructure projects. Severe weather in the Houston area often causes physical damage and leads to litigation or regulatory scrutiny regarding service reliability. The company also depends on NRG Energy and Vistra for a significant portion of its billing receivables, creating concentration risk if those entities face financial trouble.
Valuation comparisonCenterPoint carries a higher Forward P/E, comparing price to future earnings estimates, and a higher P/S ratio, which measures price against revenue.
MetricAlgonquin Power & UtilitiesCenterPoint EnergySector BenchmarkForward P/E16.5x22.5x20.3xP/S ratio1.9x3.0xSector benchmark uses the SPDR XLU sector ETF.
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Which stock would I buy in 2026?I'd go with CenterPoint Energy. Both companies offer the kind of steady, predictable utility business that long-term investors tend to appreciate. But one of them has an unusually exciting growth story underneath the surface.
CenterPoint serves the Greater Houston area, and right now Houston is one of the fastest-growing electricity markets in the country. Data centers, industrial expansion, and advanced manufacturing are flooding into the region, and CenterPoint is the utility at the center of it all. The company has a massive capital investment plan in place to meet that demand, raised its outlook, and is delivering consistent earnings growth. That's an eye-catching combination in the normally sleepy utility sector.
Algonquin, by contrast, is a turnaround story. It has made genuine progress by selling off its renewables business, cutting debt, and refocusing on core regulated utility operations. But it's still in recovery mode, and the dividend history gives long-term investors reason to be cautious.
When choosing between a utility in turnaround mode and one riding a genuine growth wave, I'll take the growth.
